ICD efficacy should be evaluated at implantation

Cardiac Electrophysiology Clinics

Volumn 3, Issue 4, 2011, Pages 549-558

  Markowitz, Steven M ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Clinical outcome; Defibrillation threshold; Implantable cardioverter defibrillator; Testing protocol

Indexed keywords

AMIODARONE;

CLINICAL PRACTICE; CLINICAL STUDY; DECISION MAKING; DEFIBRILLATION; DEFIBRILLATOR; DILATATION; HEART HEMODYNAMICS; HUMAN; IMPLANTATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; THROMBOEMBOLISM;

EID: 82755187616     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2011.08.002     Document Type: Review

References (54)

1. Gula L.J., Massel D., Krahn A.D., et al. Is defibrillation testing still necessary? A decision analysis and Markov model. J Cardiovasc Electrophysiol 2008, 19:400.
2. Strickberger S.A., Klein G.J. Is defibrillation testing required for defibrillator implantation?. J Am Coll Cardiol 2004, 44:88.
3. Viskin S., Rosso R. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 2008, 5:391.
4. Deale O.C., Wesley R.C., Morgan D., et al. Nature of defibrillation: determinism versus probabilism. Am J Physiol 1990, 259:H1544.
5. Singer I., Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992, 15:932.
6. Swerdlow C.D., Russo A.M., Degroot P.J. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007, 30:675.
7. Shorofsky S.R., Peters R.W., Rashba E.J., et al. Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. Pacing Clin Electrophysiol 2004, 27:218.
8. Marchlinski F.E., Flores B., Miller J.M., et al. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 1988, 62:393.
9. Epstein A.E., Ellenbogen K.A., Kirk K.A., et al. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation 1992, 86:1206.
10. Lehmann M.H., Thomas A., Nabih M., et al. Sudden death in recipients of first-generation implantable cardioverter defibrillators: analysis of terminal events. Participating investigators. J Interv Cardiol 1994, 7:487.
11. Pinski S.L., Vanerio G., Castle L.W., et al. Patients with a high defibrillation threshold: clinical characteristics, management, and outcome. Am Heart J 1991, 122:89.
12. Degroot P.J., Church T.R., Mehra R., et al. Derivation of a defibrillator implant criterion based on probability of successful defibrillation. Pacing Clin Electrophysiol 1924, 20:1997.
13. Higgins S., Mann D., Calkins H., et al. One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: an analysis from the Low Energy Safety Study (LESS). Heart Rhythm 2005, 2:117.
14. Gold M.R., Higgins S., Klein R., et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation 2002, 105:2043.
15. Bardy G.H., Ivey T.D., Allen M.D., et al. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989, 14:728.
16. Block M., Hammel D., Bocker D., et al. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994, 5:581.
17. Hodgson D.M., Olsovsky M.R., Shorofsky S.R., et al. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. Pacing Clin Electrophysiol 2002, 25:408.
18. Blatt J.A., Poole J.E., Johnson G.W., et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008, 52:551.
19. Day J.D., Olshansky B., Moore S., et al. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace 2008, 10:347.
20. Anvari A., Gottsauner-Wolf M., Turel Z., et al. Predictors of outcome in patients with implantable cardioverter defibrillators. Cardiology 1998, 90:180.
21. Russo A.M., Sauer W., Gerstenfeld E.P., et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2005, 2:456.
22. Shukla H.H., Flaker G.C., Jayam V., et al. High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol 2003, 26:44.
23. Theuns D.A., Szili-Torok T., Jordaens L.J. Defibrillation efficacy testing: long-term follow-up and mortality. Europace 2005, 7:509.
24. Verma A., Kaplan A.J., Sarak B., et al. Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation. J Interv Card Electrophysiol 2010, 29:127.
25. Pires L.A., Johnson K.M. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough?. J Cardiovasc Electrophysiol 2006, 17:140.
26. Mainigi S.K., Cooper J.M., Russo A.M., et al. Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. Heart Rhythm 2006, 3:1010.
27. Michowitz Y., Lellouche N., Contractor T., et al. Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace 2011, 13(5):683-688.
28. Schuger C., Ellenbogen K.A., Faddis M., et al. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006, 17:247.
29. Khalighi K., Daly B., Leino E.V., et al. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 1997, 79:150.
30. Raitt M.H., Johnson G., Dolack G.L., et al. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol 1995, 25:1576.
31. Schwartzman D., Concato J., Ren J.F., et al. Factors associated with successful implantation of nonthoracotomy defibrillation lead systems. Am Heart J 1996, 131:1127.
32. Anderson K.P. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol 2005, 14:71.
33. Mitchell L.B., Pineda E.A., Titus J.L., et al. Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002, 39:1323.
34. Pires L.A., Hull M.L., Nino C.L., et al. Sudden death in recipients of transvenous implantable cardioverter defibrillator systems: terminal events, predictors, and potential mechanisms. J Cardiovasc Electrophysiol 1999, 10:1049.
35. Lerman B.B., Engelstein E.D. Metabolic determinants of defibrillation. Role of adenosine. Circulation 1995, 91:838.
36. Mainigi S.K., Callans D.J. How to manage the patient with a high defibrillation threshold. Heart Rhythm 2006, 3:492.
37. Hall B., Jeevanantham V., Levine E., et al. Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing. Cardiol J 2007, 14:463.
38. Bianchi S., Ricci R.P., Biscione F., et al. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Pacing Clin Electrophysiol 2009, 32:573.
39. Alter P., Waldhans S., Plachta E., et al. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005, 28:926.
40. Steinbeck G., Dorwarth U., Mattke S., et al. Hemodynamic deterioration during ICD implant: predictors of high-risk patients. Am Heart J 1994, 127:1064.
41. Birnie D., Tung S., Simpson C., et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008, 5:387.
42. Runsio M., Kallner A., Kallner G., et al. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release. Am J Cardiol 1997, 79:1241.
43. Rollan M.J., San Roman J.A., Bratos J.L., et al. Acute pulmonary edema secondary to myocardial damage after electrical cardioversion. Pacing Clin Electrophysiol 2003, 26:2330.
44. Stein K.M., Devereux R.B., Hahn R.T., et al. Effect of transthoracic shocks on left ventricular function. Resuscitation 2005, 66:309.
45. Day J.D., Doshi R.N., Belott P., et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation with Implantable Cardioverter-Defibrillator Implantations). Circulation 2007, 115:2382.
46. Swerdlow C.D. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001, 103:2159.
47. Kenigsberg D.N., Mirchandani S., Dover A.N., et al. Sensing failure associated with the Medtronic Sprint Fidelis defibrillator lead. J Cardiovasc Electrophysiol 2008, 19:270.
48. Natale A., Sra J., Axtell K., et al. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations. Circulation 1996, 93:91.
49. Kron J., Herre J., Renfroe E.G., et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001, 141:92.
50. Neuzner J. Safety margins: lessons from the Low Energy Endotak Trial (LEET). Am J Cardiol 1996, 78:26.
51. Strickberger S.A., Daoud E.G., Davidson T., et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 1997, 96:1217.
52. Tokano T., Bach D., Chang J., et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998, 9:791.
53. Gold M.R., Olsovsky M.R., Pelini M.A., et al. Comparison of single- and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998, 31:1391.
54. Reynolds C.R., Nikolski V., Sturdivant J.L., et al. Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm 2010, 7:1561.